News

$9M ASAP (Aligning Science Across Parkinson’s) grant

The Khurana lab and collaborators have been selected to be part of the first cohort of global ASAP teams, funded $161M to  to understand how genes and the immune system contribute to developing Parkinson’s. You can read about this grant here, here and here.

The Ken Griffin prize will see us working with colleagues at MGH to seek an elusive diagnostic for Parkinson’s and related disorders, namely a radiotracer tool to image the protein that aggregates in the brain of patients, alpha-synuclein.

Finally, an NIH R01 will fund the Khurana lab and a team of international collaborators tofurther our understanding of alpha-synuclein aggregation in novel human stem cell models of synucleinopathies, including Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy.

Kelly graduated yesterday with a B.A. in Human Developmental and Regenerative Biology Cum Laude…Congratulations Kelly!!!

Khurana lab thrilled to welcome Baby #1 – congratulations to Isabel and Bryan on the arrival of Baby Evan!!!!

A case that we learned a lot from. Great to be able to share the knowledge –  CANVAS secondary to RFC1 expansion. Thanks to NEJM CPC!

Congratulations Xiou!!

The George C. Cotzias Fellowship is awarded by the American Parkinson Disease Association annually. Read about it here, and read about George Cotzias, who played a pivotal role in bringing L-DOPA treatment to Parkinson’s patients,  here.

Vik chairs annual HSCI retreat with Jon Hoggatt. Aazam, Zoe and Vik meet at Zoe’s poster.

Our collaborators at the Garvan Institute and other Australian institutions secure an A$30 million grant from the Australian government to design smarter clinical trials. We will be involved in the stem-cell and computational genomics platforms for the trial!

Khurana lab and collaborators win $500K Brigham Research Institute (BRI) Director’s Transformative Award for our project, “A Multidisciplinary Program at Brigham to Stratify and Precisely Target Neurodegenerative Disease.” The project focuses on using genetic and stem-cell technologies to better stratify patients with Parkinson’s disease and related disorders for therapies. The project is a collaboration between investigators in the Brigham’s Department of Neurology, Division of Genetics and Department of Pathology. Our collaborators include Tim Bartels, PhD, and Ulf Dettmer, PhD, both of Neurology; Mel Feany, MD, PhD, of Pathology; and Shamil Sunyaev, PhD, and Stephen J. Elledge, PhD, both of Genetics.

Thrilled to be named Robertson Stem Cell Investigator of the New York Stem Cell Foundation. Full credit to the @khurana_lab team at @BrighamWomens. I hope with your help we can help move the needle for patients with Parkinsons, MSA and Ataxia!